CPT 80353 Cocaine Detection — Reimbursement

CPT code 80353 denotes a laboratory toxicology assay to detect or quantify cocaine in a patient specimen. This code is used by clinical and hospital laboratories to document testing for cocaine exposure, a relevant service for clinical care, forensic evaluation, substance use treatment, and workplace or legal testing. Nationally, cocaine testing remains an important component of clinical toxicology and public health surveillance, influencing treatment decisions and care coordination.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how CPT code 80353 is billed across major payers, typical sites of service, and the clinical context for ordering cocaine assays.

Readers will learn a concise definition of the service represented by the code, typical laboratory settings where it is performed, payer coverage landscape, and what benchmark and policy elements are relevant for administrative and billing teams. The content summarizes available operational considerations for coding and documentation and highlights where input data was not available. Data not available in the input includes associated taxonomies, ICD-10 diagnoses, and related codes.

Billing Code Overview

CPT code 80353 describes a laboratory test in which a lab analyst measures the amount of or detects the presence of cocaine in a patient specimen. This service is a toxicology/drug screening laboratory procedure performed on biological specimens to identify cocaine or its metabolites.

Service type: Clinical laboratory toxicology assay
Typical site of service: Clinical laboratory or hospital laboratory setting

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical Context

A 28-year-old adult presents to an outpatient addiction medicine clinic after an initial intake screening raised concern for possible cocaine use. The clinic collects a urine specimen at the visit for toxicology screening. The specimen is submitted to the laboratory, where a certified medical technologist performs an immunoassay screen followed by confirmatory testing for cocaine metabolites. The laboratory documents specimen accessioning, analytic method, and results in the electronic laboratory information system. Test ordering is typically by the treating physician or authorized provider; results are used for treatment planning, medication management, counseling, workplace testing, or forensic review when required.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing for the professional interpretation component only if applicable (rare for tox screens).
`52`	Reduced services	Use when the lab performed a limited analysis compared with the full test.

Taxonomy Code	Specialty	Notes
`207P00000X`	Pathology	Laboratory direction and interpretation oversight for toxicology testing.
`208000000X`	General Practice	Ordering providers in primary care or addiction medicine who request testing.
`333600000X`	Addiction Medicine	Common ordering specialty for substance use testing and treatment follow-up.
`163W00000X`	Emergency Medicine	Emergency department ordering for suspected acute intoxication.
`207L00000X`	Clinical Laboratory	Performing technologists and laboratory services responsible for analysis.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F14.10`	Cocaine dependence, uncomplicated	Direct indication for cocaine testing to assess use and guide treatment planning.
`F14.20`	Cocaine dependence, uncomplicated, in remission	Used when monitoring recovery and confirming abstinence.
`F14.10`	Cocaine abuse, uncomplicated	(Note: CODING: abuse vs dependence distinctions depend on documentation)
`R78.89`	Other specified abnormal findings of blood chemistry	Used for abnormal toxicology findings when a specific substance code is not entered.
`Z71.41`	Screening for substance abuse counseling and surveillance	Used when testing is part of screening and counseling services.
`T40.5X1A`	Adverse effect of cocaine, accidental (initial encounter)	Used when testing is performed in the setting of suspected adverse effect or overdose.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80320`	Urine drug screen, presumptive, any number of drug classes; e.g., immunoassay	Often used as the initial screening method before confirmatory testing for cocaine.
`80307`	Drug confirmation; headspace gas chromatography (GC)	One of several specific confirmation methods that may be used if GC is appropriate for the analyte.
`80308`	Drug confirmation; gas chromatography/mass spectrometry (GC/MS) or mass spectrometry (MS)	Common confirmatory method for cocaine metabolites following a positive screen.
`80305`	Drug confirmation; high performance liquid chromatography (HPLC)	Alternative confirmatory method for some laboratories.
`G0480`	Drug testing confirmation by definitive drug testing (e.g., GC/MS, LC/MS)	Medicare-era code that may be used for definitive confirmatory testing workflows following presumptive positive screens.

OpenPayer

Summary & Overview

CPT 80353: Cocaine Detection Assay in Patient Specimen